Enbridge reports record Q2 2025 earnings, driven by strong liquids flows, growing power demand, and higher natural gas transmission and midstream operations.
Regeneron beats Q2 earnings estimates on strong Dupixent sales, despite challenges with Eylea and regulatory delays.
U.S. officials visit Gaza aid sites amid worsening humanitarian crisis, highlighting accusations of flawed and militarized aid distribution practices.
Enbridge reports record Q2 2025 earnings, driven by strong liquids flows, growing power demand, and higher natural gas transmission and midstream operations.
Regeneron beats Q2 earnings estimates on strong Dupixent sales, despite challenges with Eylea and regulatory delays.
U.S. officials visit Gaza aid sites amid worsening humanitarian crisis, highlighting accusations of flawed and militarized aid distribution practices.